Table 6.
No. | Name/Structure | Antimicrobial Activity (MIC or Zone of Growth) |
---|---|---|
45N | Kielcorin = −70.0° (0.01) a |
S. aureus-1199B (>512 mg/L); MRSA XU212 (>512 mg/L); S. aureus ATCC 25923 (>512 mg/L); MRSA RN4220 (>512 mg/L); EMRSA-15 (>512 mg/L); EMRSA-16 (>512 mg/L) |
46N | Mangiferin |
Bacillus pumilus (18 mm b); B. cereus (15 mm b); Salmonella enterica serotype Virchow (22 mm b); Pseudomonas aeruginosa (0 mm b); Aspergillus flavus (0 mm b; 12 mm c); Thermoascus aurantiacus (0 mm b; 18 mm c); B. cereus (40 µg/mL); Mariniluteicoccus flavus (40 µg/mL); Listeria monocytogenes (40 µg/mL); E. coli (40 µg/mL); Enterobacter cloacae (40 µg/mL); P. aeruginosa (40 µg/mL); S. typhimurium (40 µg/mL); Penicillium funiculosum (40 µg/mL); Penicillium ochrochloron (40 µg/mL); Trichoderma viride (40 µg/mL); A. fumigatos (20 µg/mL); A. niger (40 µg/mL); A. flavus (40 µg/mL); A. versicolor (20 µg/mL); C. albicans (40 µg/mL) |
47N | Buanmycin = +72.0° (0.5) a |
S. aureus (10.5 µM); B. subtilis (0.7 µM); Kocuria rhizophila (10.5 µM) |
48N | Microluside-A |
E. faecalis JH212 (10 µM); S. aureus NCTC 8325 (13 µM) |
49N | Garmoxanthone |
2strains of MRSA (3.9 µg/mL); 2 strains of Vibrio vulnificus (15.6 µg/mL); Vibrio rotiferianus (15.6 µg/mL); Vibrio campbellii (31.2 µg/mL) |
a Specific rotation measured in methanol; b The antimicrobial studies were performed by disc diffusion method, where the inhibitory growth zones inhibition caused by the tested compounds in 15% concentration and c compounds at 30% concentration are expressed in millimeters.